Filters

Pp-274 manufacturers

Filters

None products found

pp-274

Concentrate for solution for infusion

Dossier type
CTD
Dossier status
Under development
Country of origin
China
GMP approvals
China
Comments
Indication: Metastatic liver cancer Clinical stage: Phase 2 Modality: Peptide Mechanism & Target: Not disclosed Route & form: IV infusion Differentiation: it is a bispecific targets GPC3 and CD3,currently in Phase I/II clinical trials for the treatment of HCC(hepatocellular carcinoma).
Manufacturer #39685

A clinical-stage biopharmaceutical company focused on oncology. Developing a biologic therapeutic targeting oncology with global development focus. Pipeline positioned for regulatory advancement in key markets.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.